These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34118695)

  • 1. Precision dosing of methadone during pregnancy: A pharmacokinetics virtual clinical trials study.
    Badhan RKS; Gittins R
    J Subst Abuse Treat; 2021 Nov; 130():108521. PubMed ID: 34118695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of precision dosing in the use of sertraline throughout pregnancy for poor and ultrarapid metabolizer CYP 2C19 subjects: A virtual clinical trial pharmacokinetics study.
    Almurjan A; Macfarlane H; Badhan RKS
    Biopharm Drug Dispos; 2021 Jun; 42(6):252-262. PubMed ID: 33851424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision dosing of venlafaxine during pregnancy: a pharmacokinetics modelling approach.
    Alenezi M; Badhan RKS
    J Pharm Pharmacol; 2024 Jan; 76(2):122-137. PubMed ID: 38142123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimization of methadone dosing whilst treating with rifampicin: A pharmacokinetic modeling study.
    Badhan RKS; Gittins R; Al Zabit D
    Drug Alcohol Depend; 2019 Jul; 200():168-180. PubMed ID: 31122724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study.
    Burhanuddin K; Badhan R
    Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokkar M; Gothuey I; Hämmig R; Monnat M; Hüttemann H; Baumann P; Eap CB
    Clin Pharmacol Ther; 2005 Dec; 78(6):593-604. PubMed ID: 16338275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal methadone dosing schedule and fetal neurobehaviour.
    Jansson LM; Dipietro JA; Velez M; Elko A; Knauer H; Kivlighan KT
    J Matern Fetal Neonatal Med; 2009 Jan; 22(1):29-35. PubMed ID: 19085624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision dosing-based optimisation of paroxetine during pregnancy for poor and ultrarapid CYP2D6 metabolisers: a virtual clinical trial pharmacokinetics study.
    Almurjan A; Macfarlane H; Badhan RKS
    J Pharm Pharmacol; 2020 Aug; 72(8):1049-1060. PubMed ID: 32346890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
    Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
    Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.
    Ke AB; Nallani SC; Zhao P; Rostami-Hodjegan A; Unadkat JD
    Br J Clin Pharmacol; 2014 Mar; 77(3):554-70. PubMed ID: 23834474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2B6 and ABCB1 genotypes predict methadone plasma exposure among patients on maintenance therapy against opioid addictions in Tanzania.
    Mugusi S; Mnkugwe RH; Sanga AA; Salahuddin A; Barclay V; Shayo G; Dahl ML; Aklillu E
    Br J Clin Pharmacol; 2024 Jul; ():. PubMed ID: 38993001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid dependence and pregnancy: minimizing stress on the fetal brain.
    McCarthy JJ; Leamon MH; Finnegan LP; Fassbender C
    Am J Obstet Gynecol; 2017 Mar; 216(3):226-231. PubMed ID: 27729254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.
    Victorri-Vigneau C; Verstuyft C; Bouquié R; Laforgue EJ; Hardouin JB; Leboucher J; Le Geay B; Dano C; Challet-Bouju G; Grall-Bronnec M
    Br J Clin Pharmacol; 2019 Jul; 85(7):1538-1543. PubMed ID: 30907440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy.
    Gordon AL; Lopatko OV; Somogyi AA; Foster DJ; White JM
    Br J Clin Pharmacol; 2010 Dec; 70(6):895-902. PubMed ID: 21175445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2D6 genotype and methadone steady-state concentrations.
    Eap CB; Broly F; Mino A; Hämmig R; Déglon JJ; Uehlinger C; Meili D; Chevalley AF; Bertschy G; Zullino D; Kosel M; Preisig M; Baumann P
    J Clin Psychopharmacol; 2001 Apr; 21(2):229-34. PubMed ID: 11270921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
    de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA
    Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing and monitoring of methadone in pregnancy: literature review.
    Shiu JR; Ensom MH
    Can J Hosp Pharm; 2012 Sep; 65(5):380-6. PubMed ID: 23129867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal assessment before and after dosing with buprenorphine or methadone.
    Salisbury AL; Coyle MG; O'Grady KE; Heil SH; Martin PR; Stine SM; Kaltenbach K; Weninger M; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):36-44. PubMed ID: 23106925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic evidence to support clinical decision making for peripartum methadone treatment.
    Bogen DL; Perel JM; Helsel JC; Hanusa BH; Romkes M; Nukui T; Friedman CR; Wisner KL
    Psychopharmacology (Berl); 2013 Jan; 225(2):441-51. PubMed ID: 22926004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
    Chang Y; Fang WB; Lin SN; Moody DE
    Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.